Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative IV Lidocaine in Elective Cesarean Section
NCT06433713Phase 2Completed
- Sponsor
- Cairo University
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, postoperative ileus (POI), sponsored by Cairo University. Started Dec 2023; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painpostoperative ileus (POI)
Beyond the preview
Go deeper on NCT06433713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06433713.